NASDAQ : NCNA
NuCana plc — Financial statements
Healthcare · Biotechnology · United Kingdom
Last price 1.04 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in GBP.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 5.24M | 8.08M | 4.97M | 6.03M | 7.27M | 8.51M |
| Research & Development | 9.37M | 12.74M | 18.02M | 25.06M | 36.43M | 36.83M |
| Operating Expenses | 14.61M | 20.81M | 22.99M | 31.10M | 43.70M | 45.34M |
| Operating Income | -14.61M | -20.81M | -22.99M | -31.10M | -43.70M | -45.34M |
| Interest Expense | -20.00K | -20.00K | -17.00K | -29.00K | -21.00K | -18.00K |
| Interest & Investment Income | 603.00K | 386.00K | 358.00K | 754.00K | 669.00K | 103.00K |
| Currency Exchange Gain (Loss) | 396.00K | -118.00K | 229.00K | -1.16M | 4.89M | 267.00K |
| Other Non Operating Income (Expenses) | 1.85M | -10.80M | ||||
| EBT Excluding Unusual Items | -11.78M | -31.36M | -22.42M | -31.53M | -38.16M | -44.99M |
| Asset Writedown | -33.00K | -503.00K | -292.00K | -2.81M | ||
| Pretax Income | -10.94M | -30.52M | -22.45M | -32.03M | -38.45M | -47.80M |
| Income Tax Expense | -1.23M | -1.17M | -3.45M | -4.40M | -6.43M | -7.27M |
| Net Income | -9.71M | -29.35M | -19.00M | -27.63M | -32.02M | -40.53M |
| Net Income to Common | -9.71M | -29.35M | -19.00M | -27.63M | -32.02M | -40.53M |
| Shares Outstanding (Basic) | 4.07M | 2.25M | 14.84K | 10.52K | 10.45K | 10.41K |
| Shares Outstanding (Diluted) | 4.07M | 2.25M | 14.84K | 10.52K | 10.45K | 10.41K |
| EPS (Basic) | -2.39 | -13.07 | -1,280.29 | -2,627.86 | -3,065.09 | -3,894.41 |
| EPS (Diluted) | -2.39 | -13.07 | -1,280.29 | -2,627.86 | -3,065.09 | -3,894.41 |
| Free Cash Flow | -5.12M | -7.47M | -19.12M | -26.44M | -23.17M | -23.89M |
| Free Cash Flow Per Share | -1.26 | -3.32 | -1,288.72 | -2,514.79 | -2,217.86 | -2,295.16 |
| EBITDA | -14.40M | -20.60M | -22.67M | -30.73M | -43.23M | -44.67M |
| D&A For EBITDA | 212.00K | 209.00K | 314.00K | 363.00K | 461.00K | 676.00K |
| EBIT | -14.61M | -20.81M | -22.99M | -31.10M | -43.70M | -45.34M |
Balance sheet
Fiscal year January - December; amounts in GBP.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 19.50M | 24.25M | 6.75M | 17.23M | 41.91M | 60.26M |
| Cash & Short-Term Investments | 19.50M | 24.25M | 6.75M | 17.23M | 41.91M | 60.26M |
| Other Receivables | 2.50M | 1.80M | 4.62M | 5.16M | 6.42M | 7.20M |
| Receivables | 2.50M | 1.80M | 4.62M | 5.16M | 6.42M | 7.20M |
| Prepaid Expenses | 829.00K | 746.00K | 877.00K | 1.97M | 3.31M | 3.15M |
| Other Current Assets | 62.00K | 21.00K | 663.00K | 3.29M | 998.00K | |
| Total Current Assets | 22.83M | 26.86M | 12.27M | 25.02M | 54.92M | 71.61M |
| Property, Plant & Equipment | 622.00K | 658.00K | 197.00K | 521.00K | 866.00K | 851.00K |
| Other Intangible Assets | 2.21M | 2.20M | 2.20M | 2.13M | 2.37M | 2.41M |
| Long-Term Deferred Tax Assets | 125.00K | 117.00K | 113.00K | 143.00K | 103.00K | 60.00K |
| Other Long-Term Assets | 2.54M | |||||
| Total Assets | 25.78M | 29.83M | 14.77M | 27.81M | 58.25M | 77.47M |
| Accounts Payable | 450.00K | 522.00K | 2.71M | 3.38M | 4.80M | 1.83M |
| Accrued Expenses | 4.34M | 4.25M | 5.85M | 9.10M | 10.16M | 9.68M |
| Current Portion of Leases | 35.00K | 20.00K | 73.00K | 206.00K | 243.00K | 207.00K |
| Other Current Liabilities | 40.00K | 4.10M | ||||
| Total Current Liabilities | 4.83M | 4.79M | 8.67M | 12.68M | 19.31M | 11.72M |
| Long-Term Leases | 637.00K | 656.00K | 117.00K | 190.00K | 396.00K | 164.00K |
| Other Long-Term Liabilities | 58.00K | 58.00K | 37.00K | 58.00K | 46.00K | 46.00K |
| Total Liabilities | 5.52M | 5.51M | 8.82M | 12.92M | 19.75M | 11.93M |
| Common Stock | 14.34M | 14.34M | 5.68M | 2.11M | 2.10M | 2.09M |
| Additional Paid-In Capital | 175.31M | 175.25M | 146.15M | 141.31M | 141.11M | 141.05M |
| Retained Earnings | -253.75M | -252.33M | -224.29M | -207.71M | -180.57M | -149.73M |
| Treasury Stock | -339.00K | -339.00K | -339.00K | -339.00K | -339.00K | -339.00K |
| Comprehensive Income & Other | 84.69M | 87.41M | 78.76M | 79.51M | 76.21M | 72.48M |
| Shareholders' Equity | 20.26M | 24.33M | 5.95M | 14.89M | 38.50M | 65.55M |
| Total Liabilities & Equity | 25.78M | 29.83M | 14.77M | 27.81M | 58.25M | 77.47M |
| Total Debt | 672.00K | 676.00K | 190.00K | 396.00K | 639.00K | 371.00K |
| Net Cash (Debt) | 18.83M | 23.57M | 6.56M | 16.83M | 41.27M | 59.89M |
| Net Cash Per Share | 4.63 | 10.50 | 442.04 | 1,600.48 | 3,950.70 | 5,754.52 |
| Filing Date Shares Outstanding | 4.31M | 4.16M | 28.31K | 10.47K | 10.38K | 10.34K |
| Total Common Shares Outstanding | 4.31M | 4.16M | 28.31K | 10.47K | 10.38K | 10.34K |
| Working Capital | 18.00M | 22.07M | 3.60M | 12.34M | 35.61M | 59.90M |
| Book Value Per Share | 4.70 | 5.85 | 210.34 | 1,421.60 | 3,711.04 | 6,341.72 |
| Tangible Book Value | 18.05M | 22.13M | 3.75M | 12.76M | 36.14M | 63.14M |
| Tangible Book Value Per Share | 4.19 | 5.32 | 132.65 | 1,218.39 | 3,483.08 | 6,108.55 |
| Machinery | 578.00K | 558.00K | 955.00K | 941.00K | 1.09M |
Cash flow statement
Fiscal year January - December; amounts in GBP.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -9.71M | -29.35M | -19.00M | -27.63M | -32.02M | -40.53M |
| Depreciation & Amortization | 277.00K | 274.00K | 521.00K | 575.00K | 712.00K | 942.00K |
| Other Amortization | 1.00K | |||||
| Loss (Gain) From Sale of Assets | 20.00K | |||||
| Asset Writedown & Restructuring Costs | 33.00K | 503.00K | 292.00K | 2.81M | ||
| Stock-Based Compensation | 4.58M | 10.03M | 1.65M | 3.86M | 4.89M | 6.66M |
| Other Operating Activities | 734.00K | 15.26M | -139.00K | -2.46M | -774.00K | 2.20M |
| Change in Accounts Payable | -648.00K | -2.18M | -670.00K | -1.43M | 2.97M | -428.00K |
| Change in Other Net Operating Assets | -344.00K | -1.49M | -1.51M | 147.00K | 749.00K | 4.52M |
| Operating Cash Flow | -5.12M | -7.47M | -19.12M | -26.44M | -23.16M | -23.82M |
| Capital Expenditures | -4.00K | -4.00K | -12.00K | -64.00K | ||
| Sale (Purchase) of Intangibles | -208.00K | -193.00K | -289.00K | -474.00K | -506.00K | -1.00M |
| Other Investing Activities | 581.00K | 352.00K | 372.00K | 3.37M | 638.00K | -2.50M |
| Investing Cash Flow | 373.00K | 159.00K | 79.00K | 2.89M | 120.00K | -3.56M |
| Long-Term Debt Repaid | -54.00K | -223.00K | -270.00K | -227.00K | -296.00K | |
| Lease Payments | -40.00K | -54.00K | -223.00K | -270.00K | -227.00K | -296.00K |
| Net Debt Issued (Repaid) | -40.00K | -54.00K | -223.00K | -270.00K | -227.00K | -296.00K |
| Issuance of Common Stock | 19.17M | 29.06M | 8.74M | 253.00K | 66.00K | 198.00K |
| Other Financing Activities | -3.84M | -4.00M | -329.00K | -36.00K | ||
| Financing Cash Flow | 15.29M | 25.01M | 8.18M | -53.00K | -161.00K | -98.00K |
| Foreign Exchange Rate Adjustments | 515.00K | -196.00K | 379.00K | -1.08M | 4.85M | 391.00K |
| Net Cash Flow | 11.06M | 17.50M | -10.48M | -24.69M | -18.35M | -27.09M |
| Free Cash Flow | -5.12M | -7.47M | -19.12M | -26.44M | -23.17M | -23.89M |
| Free Cash Flow Per Share | -1.26 | -3.32 | -1,288.72 | -2,514.79 | -2,217.86 | -2,295.16 |
| Levered Free Cash Flow | -6.37M | -3.82M | -14.10M | -16.88M | -16.34M | -15.07M |
| Unlevered Free Cash Flow | -6.36M | -3.81M | -14.09M | -16.86M | -16.33M | -15.06M |
| Free Cash Flow After Leases | -5.16M | -7.52M | -19.34M | -26.71M | -23.40M | -24.18M |
| Cash Income Tax Paid | -3.99M | -4.01M | -5.59M | -7.22M | -9.89M | |
| Change in Working Capital | -992.00K | -3.67M | -2.18M | -1.28M | 3.72M | 4.09M |
Ratios
Fiscal year January - December; amounts in GBP.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.35M | 14.98M | 4.67M | 15.47M | 34.12M | 123.00M |
| Enterprise Value | -20.63M | -18.77M | -10.25M | -5.71M | -21.67M | 27.69M |
| Last Close Price | 1.01 | 3.60 | 238.00 | 1,479.00 | 3,300.00 | 11,900.00 |
| PB Ratio | 0.16 | 0.46 | 0.63 | 0.82 | 0.73 | 1.39 |
| P/TBV Ratio | 0.18 | 0.50 | 0.99 | 0.95 | 0.78 | 1.44 |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 |
| Net Debt / Equity Ratio | -0.93 | -0.97 | -1.10 | -1.13 | -1.07 | -0.91 |
| Net Debt / EBITDA Ratio | 1.31 | 1.14 | 0.29 | 0.55 | 0.95 | 1.34 |
| Net Debt / FCF Ratio | 3.68 | 3.16 | 0.34 | 0.64 | 1.78 | 2.51 |
| Quick Ratio | 4.56 | 5.44 | 1.31 | 1.77 | 2.50 | 5.76 |
| Current Ratio | 4.73 | 5.60 | 1.42 | 1.97 | 2.84 | 6.11 |
| Return on Equity (ROE) | -70.26% | -193.87% | -182.30% | -103.51% | -61.55% | -49.20% |
| Return on Assets (ROA) | -43.49% | -58.32% | -67.48% | -45.16% | -40.24% | -30.59% |
| Return on Capital Employed (ROCE) | -69.70% | -83.10% | -376.40% | -205.50% | -112.20% | -69.00% |
| Earnings Yield | -313.78% | -263.68% | -509.16% | -227.55% | -113.08% | -44.62% |
| FCF Yield | -158.02% | -67.08% | -512.51% | -217.76% | -81.82% | -26.30% |
| Buyback Yield / Dilution | -1,367.87% | -15,038.86% | -41.11% | -0.65% | -0.38% |